LLY

1,159.67

+1.84%↑

JNJ

238

-0.36%↓

ABBV

224.7

-0.26%↓

UNH

405.21

-0.45%↓

MRK

120.56

+1.31%↑

LLY

1,159.67

+1.84%↑

JNJ

238

-0.36%↓

ABBV

224.7

-0.26%↓

UNH

405.21

-0.45%↓

MRK

120.56

+1.31%↑

LLY

1,159.67

+1.84%↑

JNJ

238

-0.36%↓

ABBV

224.7

-0.26%↓

UNH

405.21

-0.45%↓

MRK

120.56

+1.31%↑

LLY

1,159.67

+1.84%↑

JNJ

238

-0.36%↓

ABBV

224.7

-0.26%↓

UNH

405.21

-0.45%↓

MRK

120.56

+1.31%↑

LLY

1,159.67

+1.84%↑

JNJ

238

-0.36%↓

ABBV

224.7

-0.26%↓

UNH

405.21

-0.45%↓

MRK

120.56

+1.31%↑

Search

Supernus Pharmaceuticals Inc

Atvērts

SektorsVeselības aprūpe

45.47 0.64

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

43.41

Max

45.82

Galvenie mērījumi

By Trading Economics

Ienākumi

36M

-2.3M

Pārdošana

-3.9M

208M

P/E

Sektora vidējais

48.435

49.052

EPS

0.21

Peļņas marža

-1.104

Darbinieki

778

EBITDA

-72M

19M

Rekomendācijas

By TipRanks

Rekomendācijas

Pirkt (spēcīgs)

Prognoze 12 mēnešiem

+39.17% upside

Dividendes

By Acuity

Nākamie ieņēmumi

2026. g. 4. aug.

Tirgus statistika

By TradingEconomics

Tirgus kapitalizācija

-219M

2.6B

Iepriekšējā atvēršanas cena

44.83

Iepriekšējā slēgšanas cena

45.47

Ziņu noskaņojums

By Acuity

100%

0%

320 / 344 Rangs Healthcare

Supernus Pharmaceuticals Inc Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2026. g. 10. jūn. 23:53 UTC

News
Correlated Moves

Silver/GBP declines amid geopolitical tensions in Iran and rising U.S. inflation, breaking a recent trend of higher daily closes. Gold also trades lower.

2026. g. 10. jūn. 23:52 UTC

News
Correlated Moves

SPDR Gold Shares are trading lower after reports of explosions in Tehran raise regional stability concerns, prompting investors to seek safe-haven assets.

2026. g. 10. jūn. 23:52 UTC

News
Correlated Moves

Silver/JPY is trading lower as geopolitical tensions in Iran affect investor sentiment and contribute to fluctuations in precious metals. Gold's decline also impacts silver prices.

2026. g. 10. jūn. 23:52 UTC

News
Correlated Moves

Silver prices are lower amid geopolitical tensions in Iran and rising U.S. inflation, breaking a recent trend of higher daily closes.

2026. g. 10. jūn. 23:52 UTC

News
Correlated Moves

Silver/CAD declines amid geopolitical tensions in Iran and rising U.S. inflation, reversing a trend of higher daily closes. Gold also trades lower in correlation.

2026. g. 10. jūn. 23:52 UTC

News
Correlated Moves

Silver declines amid geopolitical tensions in Iran and rising U.S. inflation, breaking a recent trend of higher daily closes. Gold also shows a downward movement.

2026. g. 10. jūn. 23:51 UTC

News
ETF Constituents

The Vanguard Growth ETF is lower in after-market hours, impacted by declines in major holdings like Amazon and AMD amid broader geopolitical tensions.

2026. g. 10. jūn. 23:46 UTC

News

Starbucks Corp reported strong Q2 results and positive FY26 guidance. Shares are modestly higher in after-market trading, recovering from an earlier dip.

2026. g. 10. jūn. 23:44 UTC

News
Social Media
ETF Constituents
Correlated Moves

Invesco QQQ Trust trades lower in after-market hours amid rising geopolitical tensions and inflation concerns, reflecting declines in major holdings like AMD.

2026. g. 10. jūn. 23:42 UTC

News
Social Media

Tesla Inc shares are lower in after-market hours amid broader market declines. The company has started delivering its Cybertruck variant priced at $59,990.

2026. g. 10. jūn. 23:41 UTC

Macro News
News
ETF Constituents
Correlated Moves

Vanguard Information Technology ETF is lower in after-market hours amid declining tech stocks and rising geopolitical tensions between the U.S. and Iran.

2026. g. 10. jūn. 23:41 UTC

News
Correlated Moves
Social Media

AMD declines in after-market trading amid AI demand concerns.

2026. g. 10. jūn. 23:41 UTC

News
Social Media
Correlated Moves

Micron Technology Inc. shares are lower in after-market hours amid a broader market decline and ongoing pressures in the semiconductor sector.

2026. g. 10. jūn. 23:31 UTC

News
Correlated Moves

The iShares 20+ Year Treasury Bond ETF is lower in after-market hours, following CPI data that raised inflation concerns and speculation on Federal Reserve policies.

2026. g. 10. jūn. 23:31 UTC

News
Correlated Moves

Intel Corp shares are lower in after-market hours amid broader market declines and ongoing geopolitical tensions affecting investor sentiment in the semiconductor sector.

2026. g. 10. jūn. 23:31 UTC

News
ETF Constituents
Correlated Moves

The iShares Russell 2000 ETF is trading lower in after-market hours, following a decline in the Russell 2000 Index amid inflation concerns.

2026. g. 10. jūn. 23:22 UTC

News
Social Media
Correlated Moves
ETF Constituents

SPDR S&P 500 ETF Trust declines in after-market trading amid broader market weakness. Concerns rise as SPY breaks below $724 and geopolitical tensions persist.

2026. g. 10. jūn. 23:21 UTC

News

iShares Silver Trust declines in after-market hours amid geopolitical tensions and rising U.S. inflation, breaking a recent trend of higher daily closes.

2026. g. 10. jūn. 23:12 UTC

News
Social Media
Correlated Moves

Meta Platforms is lower in after-market hours amid a broader market decline. The company is building a data center in Gujarat, India.

2026. g. 10. jūn. 23:11 UTC

News

Silver is trading higher during Wednesday's session, influenced by geopolitical tensions in Iran that may affect regional stability and global supply chains.

2026. g. 10. jūn. 23:06 UTC

News
Correlated Moves
Macro Event

Ethereum is trading lower amid rising inflation concerns and geopolitical tensions. The asset's decline aligns with Bitcoin's recent drop in market sentiment.

2026. g. 10. jūn. 23:03 UTC

News
Correlated Moves
Social Media

Microsoft shares are lower in after-market hours amid reports of significant layoffs in its Xbox division as part of a restructuring effort.

2026. g. 10. jūn. 23:02 UTC

News

United States Oil Fund LP gains in after-market trading amid military strikes on Iran, reflecting heightened geopolitical tensions and their impact on crude oil sentiment.

2026. g. 10. jūn. 23:02 UTC

News
ETF Constituents
Social Media
Correlated Moves

U.S. stock indices fell in after-market hours, driven by rising energy costs and inflation concerns. The SPDR Dow Jones Industrial Average ETF Trust declined alongside key holdings.

2026. g. 10. jūn. 21:02 UTC

News

Incyte shares rise in after-market trading on Guggenheim target increase.

2026. g. 10. jūn. 20:07 UTC

News
Correlated Moves

USD/NOK declines as May budget deficit of -$293 billion exceeds expectations. The pair briefly rebounded earlier but has since fallen during the session.

2026. g. 10. jūn. 20:07 UTC

News
Correlated Moves

The U.S. federal budget deficit for May was -$293 billion, surpassing expectations. USD/PLN is trading higher, reflecting a cumulative increase since Tuesday.

2026. g. 10. jūn. 20:07 UTC

Correlated Moves
News
Macro Event

The U.S. federal budget deficit for May reached -$293 billion, exceeding forecasts. The USD/SEK exchange rate is advancing amid persistent inflationary pressures.

2026. g. 10. jūn. 20:07 UTC

News
Correlated Moves

U.S. federal budget deficit for May reached -$293 billion, larger than expected. USD/SGD trading roughly flat amid this macro backdrop.

2026. g. 10. jūn. 20:07 UTC

News
Macro Event
Correlated Moves

The U.S. budget deficit for May reached $293 billion, surpassing forecasts. The USD/CZK exchange rate is trading higher amid mortgage rate volatility.

Salīdzinājums

Cenas izmaiņa

Supernus Pharmaceuticals Inc Prognoze

Cenas mērķis

By TipRanks

39.17% augšup

Prognoze 12 mēnešiem

Vidējais 62.75 USD  39.17%

Augstākais 66 USD

Zemākais 55 USD

Pamatojoties uz 4 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi Supernus Pharmaceuticals Inc — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt (spēcīgs)

4 ratings

3

Pirkt

1

Turēt

0

Pārdot

Noskaņojums

By Acuity

320 / 344 Rangs Veselības aprūpe

Ziņu noskaņojums

Ļoti spēcīga liecība "Lāču" tendencei

Volatilitāte

Zem vidējā

Ziņu apjoms (RCV)

Zem vidējā

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

$

Par Supernus Pharmaceuticals Inc

Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. The company's commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prophylaxis of migraine headache; and Oxtellar XR, an extended release oxcarbazepine for the monotherapy treatment of partial onset seizures in adults and children between 6 to 17 years of age. It also offers comprise Qelbree, a novel non-stimulant indicated for the treatment of attention-deficit hyperactivity disorder (ADHD) in adults and pediatric patients 6 years and older; APOKYN for the acute intermittent treatment of hypomobility or off episodes in patients with advanced Parkinson's Disease (PD); XADAGO for treating levodopa/carbidopa in patients with PD experiencing off episodes; MYOBLOC, a Type B toxin product indicated for the treatment of cervical dystonia and sialorrhea in adults; GOCOVRI for the treatment of dyskinesia in patients with PD; and Osmolex ER for the treatment of Parkinson's disease and drug-induced extrapyramidal reaction in adult patients. In addition, the company's product candidates include SPN-830, a late-stage drug/device combination product candidate for the treatment of off episodes in PD patients; SPN-817, a novel first-in-class selective acetylcholinesterase inhibitor, which is in Phase II clinical trials for the treatment of epilepsy; SPN-820, a product candidate in Phase II clinical trials for treating resistant depression; SPN-443, a preclinical product for the treatment of ADHD/CNS; and SPN-446 for narcolepsy and SPN-448 for the treatment of CNS which is in discovery stage. It markets and sells its products through pharmaceutical wholesalers, specialty pharmacies, and distributors. Supernus Pharmaceuticals, Inc. was incorporated in 2005 and is headquartered in Rockville, Maryland.
help-icon Live chat